Who owns AADI BIOSCIENCE INC COM?
- Ticker: WHWK
- CUSIP Number: 00032q104
Tip: Access positions for across all investors
Analyze quarterly positions in Aadi Bioscience with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Aadi Bioscience stock
Who bought or sold AADI BIOSCIENCE INC COM this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| QVT Financial | 4.6M | $11M | 0% | Dec 2025 |
|
| OrbiMed Advisors | 4.2M | $7.9M | 0% | Sep 2025 |
|
| Suvretta Capital Management | 3.7M | $9.0M | 0% | Dec 2025 |
|
| Longwood Capital Partners | 3.4M | $8.3M | 0% | Dec 2025 |
|
| venBio Select Advisor | 2.8M | $6.9M | 0% | Dec 2025 |
|
| KVP Capital Advisors | 2.2M | $5.2M | 100% | Dec 2025 |
|
| Siren | 2.1M | $5.0M | 0% | Dec 2025 |
|
| Yu Fan | 2.1M | $5.0M | 0% | Dec 2025 |
|
| Vanguard Group | 1.6M | $3.8M | 18% | Dec 2025 |
|
| Stempoint Capital | 1.5M | $3.5M | 244% | Dec 2025 |
|
| Acorn Capital Advisors | 1.1M | $2.2M | 0% | Sep 2025 |
|
| Ally Bridge Group | 818k | $2.0M | 0% | Dec 2025 |
|
| Renaissance Technologies | 441k | $1.1M | -4% | Dec 2025 |
|
| Geode Capital Management | 425k | $1.0M | 11% | Dec 2025 |
|
| BlackRock | 299k | $724k | 1% | Dec 2025 |
|
| Eversept Partners | 260k | $630k | 100% | Dec 2025 |
|
| Bridgeway Capital Management | 215k | $409k | -32% | Sep 2025 |
|
| State Street Corporation | 146k | $352k | 112% | Dec 2025 |
|
| Citadel Advisors | 140k | $266k | 391% | Sep 2025 |
|
| Susquehanna International | 110k | $266k | 100% | Dec 2025 |
|
| Northern Trust | 104k | $250k | 43% | Dec 2025 |
|
| ADAR1 Capital Management | 78k | $188k | 100% | Dec 2025 |
|
| Qube Research & Technologies | 72k | $175k | 100% | Dec 2025 |
|
| Jane Street | 70k | $169k | 177% | Dec 2025 |
|
| Marshall Wace | 68k | $165k | 100% | Dec 2025 |
|
| UBS Group | 30k | $72k | 424% | Dec 2025 |
|
| Dimensional Fund Advisors | 29k | $69k | -35% | Dec 2025 |
|
| ABG Innovation Capital Partners III GP | 27k | $65k | 0% | Dec 2025 |
|
| Acadian Asset Management | 25k | $58k | -6% | Dec 2025 |
|
| XTX Topco | 16k | $38k | -21% | Dec 2025 |
|
| Quadrature Capital | 11k | $28k | 100% | Dec 2025 |
|
| Us Bancorp | 3.3k | $8.1k | 0% | Dec 2025 |
|
| Advisor Group Holdings | 3.1k | $7.4k | 0% | Dec 2025 |
|
| Bartlett & Co. Wealth Management | 1.3k | $3.2k | 0% | Dec 2025 |
|
| Jpmorgan Chase & Co | 421.00 | $799.984200 | 100% | Sep 2025 |
|
| Russell Investments | 386.00 | $934.004200 | 0% | Dec 2025 |
|
| TD Waterhouse Canada | 232.00 | $560.999200 | 0% | Dec 2025 |
|
| Bnp Paribas Arbitrage, Snc | 160.00 | $387.008000 | 0% | Dec 2025 |
|
| Group One Trading | 100.00 | $242.000000 | 100% | Dec 2025 |
|
| CWM | 25.00 | $0 | 0% | Dec 2025 |
|
| SBI Securities | 19.00 | $46.000900 | 0% | Dec 2025 |
|
| Parallel Advisors | 8.00 | $19.000000 | 0% | Dec 2025 |
|
Who sold out of Aadi Bioscience?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Peapod Lane Capital | Sep 2025 | 304k | $577k |
| Squarepoint Ops | Sep 2025 | 84k | $159k |
| Stonepine Capital Management | Sep 2025 | 35k | $67k |
| Tower Research Capital | Sep 2025 | 797.00 | $1.5k |
| Simplex Trading | Sep 2025 | 35.00 | $0 |